Bringing the fundamentals into focus…
Back to Relmada Therapeutics, Inc.
How Relmada Therapeutics, Inc. stacks up
RLMD · against 432 other Healthcare companies of similar size
Profitability
27/ 100
Below the middle of the pack.
Ranked #302 of 433 · scores higher than 29% of peers
Bars: peers in each 10-point band of the profitability score51 peers with a profitability score of 20–29, including RLMD · Click a bar to see the companies
Why profitability scores 27?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital and return on assets, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 81% of peers. Return on invested capital: -26.4% vs peer median 4.7%
- a lower return on assets: weaker than 65% of peers. Return on assets: -2.1% vs peer median 1.7%
- Operating margin is not reported, so it is left out of the score.
Metric by metric
Position: dot = RLMD, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | RLMD | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 402 reported | -26.4% | 1.6% | 21% | 33% | |
| Operating marginHigher is better · 406 reported | Not reported | 4.1% | — | — | 33% |
| Return on assetsHigher is better · 432 reported | -2.1% | 0.9% | 39% | 33% | |
| Return on equityHigher is better · 412 reported | -55.7% | 0.7% | 14% | Context only | |
| Gross marginHigher is better · 452 reported | 0.0% | 39.5% | 4% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by profitability score
Top 5 and the companies ranked around RLMD| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 302 | 3.1B CNY (≈$440M) | 27 | 18 | |
| 302 | 3.4B CNY (≈$469M) | 27 | 42 | |
| 302 | 14.9B TWD (≈$462M) | 27 | 42 | |
| 302 | 318M USD | 27 | 26 | |
| 302 | 455M USD | 27 | 53 | |
| 307 | 6.3B CNY (≈$878M) | 26 | 32 | |
| 307 | 2.1B CNY (≈$301M) | 26 | 21 | |
| 307 | 4.0B CNY (≈$563M) | 26 | 18 | |
| 307 | 467M USD | 26 | 44 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score